195 related articles for article (PubMed ID: 33831865)
1. Olfactory Dysfunction and Cognition in Radiologically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis.
Arici Duz O; Saatci O; Karakulak EZ; Birday E; Hanoglu L
Eur Neurol; 2021; 84(3):175-182. PubMed ID: 33831865
[TBL] [Abstract][Full Text] [Related]
2. Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies.
Wnuk M; Drabik L; Marona M; Szaleniec J; Bryll A; Karcz P; Kolasinska J; Kolasinska M; Ziekiewicz M; Skladzien J; Popiela T; Slowik A
Ear Nose Throat J; 2022 Dec; 101(10):640-644. PubMed ID: 33236917
[TBL] [Abstract][Full Text] [Related]
3. Olfactory identification associates with cognitive function and the third ventricle width in patients with relapsing-remitting multiple sclerosis.
Okada K; Kakeda S; Tahara M
Mult Scler Relat Disord; 2020 Feb; 38():101507. PubMed ID: 31766000
[TBL] [Abstract][Full Text] [Related]
4. The effects of cognition, quality of life, and fatigue on olfactory function in patients with multiple sclerosis.
Acikgoz M; Piri Cinar B; Aciman Demirel E; Celebi U; Cekic S; Elicora S; Atasoy HT
Clin Neurol Neurosurg; 2023 Jun; 229():107739. PubMed ID: 37146370
[TBL] [Abstract][Full Text] [Related]
5. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
6. Olfactory Dysfunction Reflects Disease Progression in Japanese Patients with Multiple Sclerosis.
Okada K; Kakeda S; Tahara M
Intern Med; 2022 Nov; 61(21):3181-3187. PubMed ID: 35400704
[TBL] [Abstract][Full Text] [Related]
7. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
8. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
[TBL] [Abstract][Full Text] [Related]
9. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
[TBL] [Abstract][Full Text] [Related]
10. Transient impairment of olfactory threshold in acute multiple sclerosis relapse.
Bsteh G; Hegen H; Ladstätter F; Berek K; Amprosi M; Wurth S; Auer M; Di Pauli F; Deisenhammer F; Lutterotti A; Berger T
Mult Scler Relat Disord; 2018 Jul; 23():74-77. PubMed ID: 29783156
[TBL] [Abstract][Full Text] [Related]
11. Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis.
Joly H; Capet N; Mondot L; Cohen M; Suply C; Bresch S; Lebrun-Frenay C
Mult Scler Relat Disord; 2020 Sep; 44():102374. PubMed ID: 32652509
[TBL] [Abstract][Full Text] [Related]
12. Olfactory functioning in early multiple sclerosis: Sniffin' Sticks Test study.
Batur Caglayan HZ; Irkec C; Nazliel B; Akyol Gurses A; Capraz I
Neuropsychiatr Dis Treat; 2016; 12():2143-7. PubMed ID: 27621629
[TBL] [Abstract][Full Text] [Related]
13. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
14. Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.
Carotenuto A; Costabile T; Moccia M; Falco F; Scala MR; Russo CV; Saccà F; De Rosa A; Lanzillo R; Brescia Morra V
Mult Scler Relat Disord; 2019 Jan; 27():1-6. PubMed ID: 30273697
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
16. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
17. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.
Thouvenot E; Hinsinger G; Demattei C; Uygunoglu U; Castelnovo G; Pittion-Vouyovitch S; Okuda D; Kantarci O; Pelletier D; Lehmann S; Marin P; Siva A; Lebrun C
Mult Scler; 2019 Apr; 25(5):669-677. PubMed ID: 29564952
[TBL] [Abstract][Full Text] [Related]
19. Impulsivity and attention deficit-hyperactivity symptoms among patients with relapsing-remitting multiple sclerosis: a case-control study.
Ceyhun HA; Bilge N; Değirmencioğlu Gök D
Neurol Res; 2024 Mar; 46(3):243-252. PubMed ID: 38088158
[TBL] [Abstract][Full Text] [Related]
20. Measuring productivity loss in early relapsing-remitting multiple sclerosis.
Sainz de la Maza S; Maurino J; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco MR; García-Soto JD; Campo-Amigo MD; Navarro-Cantó L; Agüera E; Garcés M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; de Alda LR; Gómez-Ballesteros R; Castillo-Triviño T
Mult Scler Relat Disord; 2022 Feb; 58():103398. PubMed ID: 35216781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
